Patent · US Active

HIV-1 neutralizing antibodies and uses thereof

US11071783B2 · kind B2 · utility

1Cited by
3References
26Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 21, 2016
Grant dateJul 27, 2021
Priority date
Expiry dateApr 25, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to HIV-1 neutralizing antibodies and methods for their uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.